Masco shares plunged -10.51% in regular trading following the company's Q2 2026 earnings release, dropping from a prior close of $81.61 to approximately $73.03. The decline was triggered by a Q2 revenue miss of $1.99 billion versus the $2.08 billion consensus, representing a -3% year-over-year decline, despite adjusted EPS of $1.64 beating estimates by 25%.

LII shares fell -14.79% during regular trading after reporting Q2 2026 results before the market opened, erasing months of gains in a single session. Q2 revenue of $1.55B narrowly missed the $1.56B consensus estimate, while GAAP EPS of $7.72 was roughly in line with the $7.73 analyst consensus.

BSX dropped -5.88% during premarket and early regular trading after reporting Q2 2026 results that beat estimates but included a sharp guidance cut. Q2 earnings topped consensus: adjusted EPS of $0.86 vs. $0.83 expected, and revenue of $5.44 billion vs. $5.36 billion, driven by 7.5% year-over-year sales growth.

VRT tumbled approximately -10.1% during regular trading Wednesday after its Q2 2026 earnings report beat on profit but missed on revenue, triggering a sharp selloff. Adjusted EPS of $1.52 surpassed the $1.42 consensus by +6.4%, yet revenue of $3.27B fell roughly -3.4% short of the $3.38B analyst estimate, overshadowing the bottom-line beat.

Profit surge: Underlying earnings jumped 43% year-over-year to $6.85 billion for the half year ended June 30, 2026, the highest half-year profit in four years. Revenue growth: Consolidated sales revenue rose 15% to $31.03 billion, supported by higher commodity prices and increased production volumes across key commodities.

Revenue beat: GSK posted second-quarter turnover of £8.41 billion, exceeding the analyst consensus of £8.24 billion and rising 5% at constant exchange rates (CER). Profit outperformance: Core operating profit reached £2.80 billion, ahead of the £2.68 billion consensus, while core earnings per share (EPS) of 50.5 pence comfortably beat the 47.1 pence forecast.

Core sales rose 17% year over year to $4.74 billion, surpassing the consensus estimate of approximately $4.62 billion. Core earnings per share (EPS) climbed 30% to $0.78, beating analyst expectations of $0.75 to $0.76.

Revenue topped expectations: GAAP revenue reached $4.15 billion, up 10% year-over-year, exceeding the analyst consensus of approximately $4.12 billion. Adjusted EPS beat estimates: Adjusted earnings per share came in at $4.83, a 23% increase from $3.92 a year ago, surpassing the FactSet consensus of $4.81.

Visa reported fiscal third-quarter 2026 net revenue of $11.63 billion, up 14% year-over-year, exceeding the consensus estimate of approximately $11.38 billion. Adjusted earnings per share (EPS) came in at $3.32, beating analyst expectations of $3.23 and marking an 11% increase from the prior-year period.

Revenue significantly exceeded expectations: Seagate posted fiscal Q4 2026 revenue of $3.63 billion, comfortably beating the FactSet consensus estimate of $3.5 billion and surging 49% year-over-year. Non-GAAP earnings per share (EPS) crushed estimates: Adjusted EPS came in at $5.71, well above the $5.10 analyst consensus and up 120% from $2.59 in the prior-year quarter.

Revenue beat expectations: Boeing reported Q2 revenue of $24.6 billion, exceeding the Bloomberg consensus estimate of $24.26 billion and rising 8% year-over-year. Loss wider than anticipated: Core (non-GAAP) loss per share came in at $0.76, well above the $0.28 consensus loss estimate, driven by ongoing profitability challenges.

Revenue beat: KLA posted Q4 FY2026 revenue of $3.66 billion, exceeding the consensus estimate of $3.61 billion and landing above the midpoint of its own guidance range. Earnings outperformance: Non-GAAP diluted EPS (earnings per share) came in at $1.05, surpassing analyst expectations of $1.00 per share and hitting the upper end of company guidance.

Coca-Cola exceeded Wall Street estimates in the second quarter of 2026, reporting adjusted earnings of $0.97 per share versus the $0.93 consensus and net revenues of $13.38 billion against expectations of approximately $13.16 billion. Global unit case volume grew 5% , marking a meaningful acceleration driven by FIFA World Cup marketing activation, favorable weather in select markets, and continued strength in Coca-Cola Zero Sugar, which surged 16%.

Microsoft shares have moved approximately +2.3% over the last 30 days, recovering from a June low near $349 but remaining well below the 50-day and 200-day moving averages. The stock is down roughly 21% year-to-date, making it the second-worst performer among the "Magnificent Seven" in 2026, as AI infrastructure spending fears dominate sentiment.

Micron Technology shares fell approximately 28% over the past 30 days, dropping from $1,145.28 on June 29 to $820.53 on July 28, 2026. The sell-off was driven by a sector-wide retreat from AI-linked memory stocks, renewed fears of Chinese competition after ChangXin Memory Technologies' IPO, and growing skepticism around hyperscaler AI spending.

Robinhood (HOOD) shares have pulled back approximately 8.9% over the past 30 days, trading near $92.76 as of late July 2026, ahead of the company's highly anticipated Q2 earnings report. The launch of Robinhood Chain — an Ethereum Layer-2 blockchain — has driven rapid adoption, surpassing 328,000 real-world asset holders and attracting over $325 million in total value locked within its first month.

GLW plunged -15.08% during Tuesday's regular session after reporting Q2 results that beat estimates but issuing Q3 revenue guidance that fell slightly short of elevated Street expectations. Q2 core EPS of $0.78 on $4.74B in core sales topped consensus, yet Q3 revenue guidance of $4.9B–$5.0B (midpoint $4.95B) came in just below the ~$5B analysts had penciled in.

SHAZ plunged -18.47% during regular trading hours on Tuesday, dropping from a prior close of $58.79 to $47.93, extending a multi-week rout that has erased more than half its value since early July peaks near $97. The selloff follows yesterday's -9.40% decline and reflects mounting investor anxiety ahead of the company's Q2 2026 earnings announcement, after Q1 results missed estimates with an EPS of -$1.43 versus -$0.89 expected and negligible revenue of just $1.54 million TTM.

CVLT shares plunged -15.94% during Tuesday's regular session, despite reporting fiscal Q1 (June quarter) results that beat on both adjusted EPS ($1.42 vs. $1.16 consensus) and revenue ($314.1M vs. $310.5M consensus). The sell-off was triggered by a significant miss on annual recurring revenue (ARR), which came in at $1.05 billion versus the $1.15 billion analysts had projected, while billings declined -5.9% year-over-year.

SANM plunged -19.52% during regular trading on Tuesday after reporting Q3 FY2026 results that beat on both EPS ($3.31 vs. $2.79 consensus) and revenue ($3.46B vs. $3.40B), yet disappointed with forward guidance. The selloff was driven by Q4 revenue guidance of $3.3B–$3.6B (midpoint $3.45B), which came in below the $3.52B analyst consensus, alongside a lower ZT Systems Q4 revenue outlook of $0.8B–$1.0B due to legacy program timing shifts.